Showing results (451-460 of 3,180) with videos related to

Sort By:
Pageof 318
Molecular Cancer Research : MCR|July 6, 2004
A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasmaJohn M L Ebos, Guido Bocci, Shan Man, et al.
Molecular Cancer Research : MCR|July 6, 2004
Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cellsByeong-Chel Lee, Tae-Hee Lee, Shalom Avraham, et al.
Molecular Cancer Research : MCR|March 10, 2005
Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA bindingJing Hu, Nancy H Colburn
Molecular Cancer Research : MCR|July 28, 2005
Lipopolysaccharide prevents doxorubicin-induced apoptosis in RAW 264.7 macrophage cells by inhibiting p53 activationFerdaus Hassan, Shamima Islam, Mya Mya Mu, et al.
Molecular Cancer Research : MCR|July 28, 2005
Proteasome structures affected by ionizing radiationMilena Pervan, Keisuke S Iwamoto, William H McBride
Molecular Cancer Research : MCR|July 28, 2005
Phosphorylation of AML1/RUNX1 regulates its degradation and nuclear matrix associationJoseph R Biggs, Youhong Zhang, Luke F Peterson, et al.
Molecular Cancer Research : MCR|March 31, 2005
Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sitesHideshi Ishii, Koshi Mimori, Taeko Inageta, et al.
Molecular Cancer Research : MCR|March 31, 2005
The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivationRebecca L Lynch, Bruce W Konicek, Ann M McNulty, et al.
Molecular Cancer Research : MCR|August 27, 2005
Sensitivity to DNA damage is a common component of hormone-based strategies for protection of the mammary glandYifan Tu, D Joseph Jerry, Brooke Pazik, et al.
Molecular Cancer Research : MCR|May 12, 2005
E1A specifically enhances sensitivity to topoisomerase IIalpha targeting anticancer drug by up-regulating the promoter activityZhichao Zhou, Hui Guan, Eugenie S Kleinerman
Pageof 318